Mass General Cancer Center at Newton-Wellesley — Newton, Massachusetts

Mass General Cancer Center at Newton-Wellesley is a clinical research site located in Newton, Massachusetts, United States 02462.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass General Cancer Center at Newton-Wellesley has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Neoplasms, Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma.

Sponsors: Eli Lilly and Company, Epizyme, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Cancer Center at Newton-Wellesley?

Mass General Cancer Center at Newton-Wellesley has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Cancer Center at Newton-Wellesley conducted?

Mass General Cancer Center at Newton-Wellesley has 2 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasms, Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma.

Is Mass General Cancer Center at Newton-Wellesley accredited by Crixeo Health?

Mass General Cancer Center at Newton-Wellesley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Cancer Center at Newton-Wellesley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.